Shopping Cart
- Remove All
Your shopping cart is currently empty
AT791 is an orally available TLR7 and TLR9 inhibitor, suppressing TLR7 and TLR9 signaling, used in autoimmune lupus research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $105 | In Stock | |
| 5 mg | $259 | In Stock | |
| 10 mg | $416 | In Stock | |
| 25 mg | $826 | In Stock | |
| 50 mg | $1,190 | In Stock | |
| 100 mg | $1,860 | In Stock | |
| 200 mg | $2,480 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $286 | In Stock |
| Description | AT791 is an orally available TLR7 and TLR9 inhibitor, suppressing TLR7 and TLR9 signaling, used in autoimmune lupus research. |
| Targets&IC50 | TLR9:0.04μM, TLR7:3.33μM |
| In vitro | AT791 effectively inhibited DNA stimulation of HEK:TLR9 cells with an IC50 value of 40 nM, respectively, but was significantly less effective in inhibiting LPS endotoxin stimulation of HEK:TLR4 cells or R848 HEK:TLR7 cells. Methods: To confirm whether the interaction of AT791 with DNA was associated with its ability to inhibit DNA-TLR9 interaction in cells, a live cell version of the oligonucleotide bait assay was developed. A non-stimulatory version of the oligonucleotide CpG2216 was created by inverting the stimulatory CpG motif to GpC to generate GpC2216. Results: Stimulatory CpG2216 induced IL-6 production in BMDCs, whereas AT791 (10 mM) inhibited this production. However, when an excess of non-stimulatory GpC2216 was added, IL-6 induction was restored. GpC2216 itself, either alone or in the presence of AT791, does not stimulate IL-6 production.[1] |
| In vivo | Short-term induction of serum interleukin-6 by CpG1668 DNA in mice could be effectively inhibited by pretreatment with AT791 (20 mg/kg).[1] |
| Synonyms | AT 791 |
| Molecular Weight | 397.51 |
| Formula | C23H31N3O3 |
| Cas No. | 1219962-49-8 |
| Smiles | N1=C(OC=2C=C(OCCCN(C)C)C=CC12)C3=CC=C(OCCCN(C)C)C=C3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (201.25 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.